Reset filter
Palavras-chave
AML ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
    1. 7.1. Anestesia
    1. 7.2. Dermatologia
    1. 7.3. Otorrinolaringologia
    1. 7.4. Geriatria
    1. 7.5. Ginecologia/obstetrícia
    1. 7.6. Medicina interna
      1. Hematologia
      1. Infecciologia
      1. Cardiologia/angiologia
      1. Pneumologia
      1. Gastroenterologia
      1. Nefrologia
      1. Endocrinologia/metabolismo
      1. Reumatologia
    1. 7.7. Neurologia
    1. 7.8. Oftalmologia
    1. 7.9. Medicina paliativa
    1. 7.10. Patologia/medicina Legal
    1. 7.11. Pediatria
    1. 7.12. Psiquiatria/psicossomática
    1. 7.13. Radiologia
    1. 7.14. Cirurgia
      1. Cirurgia geral/abdominal
      1. Neurocirurgia
      1. Cirurgia plástica
      1. Cirurgia cardíaca/torácica
      1. Cirurgia de trauma/ortopedia
      1. Cirurgia vascular
    1. 7.15. Urologia
    1. 7.16. Odontologia/cirurgia bucomaxilofacial
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

242 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Eligibility Leukemia NCT00469820

- 03/08/2017 - 1 Formulário, 1 Grupo de itens, 15 Elementos de dados, 1 Idioma
Grupo de itens: Criteria
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT00469820

Eligibility Leukemia NCT00899171

- 19/05/2018 - 1 Formulário, 1 Grupo de itens, 10 Elementos de dados, 1 Idioma
Grupo de itens: Criteria
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00899171

Eligibility Leukemia NCT00887068

- 18/05/2018 - 1 Formulário, 2 Grupos de itens, 16 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Randomized Allogeneic Azacitidine Study; ODM derived from: https://clinicaltrials.gov/show/NCT00887068

Eligibility Leukemia NCT00775593

- 17/05/2018 - 1 Formulário, 1 Grupo de itens, 23 Elementos de dados, 1 Idioma
Grupo de itens: Criteria
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00775593

Eligibility Leukemia NCT00554489

- 16/05/2018 - 1 Formulário, 1 Grupo de itens, 15 Elementos de dados, 1 Idioma
Grupo de itens: Criteria
Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00554489

Eligibility Leukemia NCT00544999

- 16/05/2018 - 1 Formulário, 7 Grupos de itens, 22 Elementos de dados, 1 Idioma
Grupos de itens: Criteria, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria, Exclusion Criteria
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00544999

Eligibility Leukemia NCT00576979

- 04/08/2017 - 1 Formulário, 2 Grupos de itens, 19 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00576979

Eligibility Leukemia NCT01378416

- 20/04/2017 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01378416

Eligibility Leukemia NCT00460421

- 19/04/2017 - 1 Formulário, 2 Grupos de itens, 23 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT; ODM derived from: https://clinicaltrials.gov/show/NCT00460421

Eligibility Leukemia NCT00454480

- 19/04/2017 - 1 Formulário, 1 Grupo de itens, 17 Elementos de dados, 1 Idioma
Grupo de itens: Criteria
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes; ODM derived from: https://clinicaltrials.gov/show/NCT00454480

Eligibility Leukemia NCT00422591

- 19/04/2017 - 1 Formulário, 2 Grupos de itens, 10 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00422591

Eligibility Leukemia NCT00391560

- 18/04/2017 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00391560

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial